Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
Inj delandistrogene mox rokl (HCPCS J141300) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved June 29, 2026 , from http://ppman.hank.ai/transparency/procedure/J141300/by-state?code_type=HCPCS
“Inj delandistrogene mox rokl (HCPCS J141300) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/J141300/by-state?code_type=HCPCS. Accessed
June 29, 2026 .
“Inj delandistrogene mox rokl (HCPCS J141300) by State,” HANK Price Transparency ,
accessed June 29, 2026 ,
http://ppman.hank.ai/transparency/procedure/J141300/by-state?code_type=HCPCS.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
HCPCS · across United States
J141300 — Inj Delandistrogene Mox Rokl
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$3,392,000
National median
$3,392,000 – $3,392,000
IQR (p25 – p75)
2
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for J141300 (HCPCS), with interquartile range
State Median p25 p75
NY $3,392,000 $3,392,000 $3,392,000